Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations

BACKGROUND: Since there are no certified therapeutics to treat COVID-19 patients, drug repurposing became important. With lack of time to test individual pharmacogenomics markers, population pharmacogenomics could be helpful in predicting a higher risk of developing adverse reactions and treatment f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Biochem
Main Authors: Stanković, Biljana, Kotur, Nikola, Gašić, Vladimir, Klaassen, Kristel, Ristivojević, Bojan, Stojiljković, Maja, Pavlović, Sonja, Zukić, Branka
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Medical Biochemists of Serbia, Belgrade 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710379/
https://ncbi.nlm.nih.gov/pubmed/33312066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5937/jomb0-26725
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados